Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1994 Mar;69(3):529-36.
doi: 10.1038/bjc.1994.96.

Prognostic significance of histopathological subtypes in stage I pure yolk sac tumour of the ovary

Affiliations
Free PMC article
Comparative Study

Prognostic significance of histopathological subtypes in stage I pure yolk sac tumour of the ovary

H Sasaki et al. Br J Cancer. 1994 Mar.
Free PMC article

Abstract

The correlation between histological subtype [endodermal sinus (ES), polyvesicular vitelline (PV), glandular (G) and hepatoid (H) subtypes] and the prognosis of pure yolk sac tumours (YSTs) of the ovary was investigated. From 1964 to 1989, 35 patients with YSTs were treated with primary surgery and adjuvant chemotherapy. The prevalence of histological subtypes was as follows: 14 patients had a single subtype, either ES (12) or G (2); 12 patients had two subtypes, ES+G (4), ES+PV (3), ES+H (4) or G+H (1); six patients had three subtypes, ES+P+H (4) or ES+G+H (2); and three patients had all four subtypes. Multivariate analysis showed that important predictors were FIGO stage, chemotherapeutic regimen and residual tumour size. However, for stage I, multivariate analysis showed that the histological subtype was a superior predictor to the subclassification of FIGO stage I, age or chemotherapeutic regimen (P = 0.03). Kaplan-Meier analysis showed that YSTs composed of an admixture of three or four subtypes was associated with a better prognosis than those composed of one or two subtypes (P < 0.01), other variables being constant.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Oncol. 1990 Apr;8(4):715-20 - PubMed
    1. J Clin Oncol. 1986 Feb;4(2):194-9 - PubMed
    1. Cancer. 1962 May-Jun;15:546-56 - PubMed
    1. Cancer. 1963 Jan;16:34-47 - PubMed
    1. Cancer. 1959 Nov-Dec;12:1092-105 - PubMed

Publication types

MeSH terms

Substances